Volteface is accepting pitches for our website on this recent psilocybin study and what it means for psychedelic therapy. No particular deadline but the sooner the better – we’re always looking to commission pieces.
ABOUT THE COMPANY
Volteface is an independent research and advocacy organisation that seeks to reduce the harm drugs pose to individuals and society, through evidence-based policy reform. It cultivates fresh thinking and new ideas through our policy reports and online magazine.
WHAT TO INCLUDE IN SUBMISSION
More information: Interesting evidence on the use of psilocybin-assisted treatment: https://pubmed.ncbi.nlm.nih.
COMPENSATION
CONTACT
For more information, visit their visit.
Please email all questions and submissions to Katya Kowalski, Head of Operations at Volteface at katya@volteface.me.
The Advocate is looking for a savvy reporter to cover the Baton Rouge business scene…
MLex, a LexisNexis company, is an independent news organization for breaking news and forward-looking analysis…
The Austin Business Journal seeks a staff writer to cover economic development in one of…
A Russian court on Saturday placed Sergei Mingazov, a journalist for the Russian edition of…
Justin Nielsen of Investor's Business Daily writes about the newspaper's 40th anniversary. Nielsen writes, "When the…
Clare Fieseler has been hired by Politico and subsidiary E&E News to cover renewable energy,…